EMILY FECHNER: Open Payments
NPI 1669839304 · MORTON GROVE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,453 in 112 payments from 41 companies in 2025. Trend: 2023 $4,486 · 2024 $4,807 · 2025 $2,453
Food & beverage: $2,170Long term medical supply or device loan: $283
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 22 | $557 |
| Janssen Biotech, Inc. | 14 | $289 |
| ABBVIE INC. | 15 | $197 |
| Daiichi Sankyo Inc. | 11 | $153 |
| AstraZeneca Pharmaceuticals LP | 3 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $69 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Geron Corporation | 2 | $58 |
| Dendreon Pharmaceuticals LLC | 2 | $57 |
| PharmaEssentia USA Corporation | 2 | $51 |
Products named: KISQALI, TALVEY, VENCLEXTA, IMBRUVICA, Enhertu, LUTATHERA, OJJAARA, RYTELO.
Industry payments across IL — which companies pay providers there.
